Management of childhood asthma presenting with wheezing, chronic cough, and shortness of breath, using spacer-assisted inhaler therapy, maintenance controller medications, and when appropriate, the MART (Maintenance and Reliever Therapy) approach.
Indication
- Recurrent wheezing, dry cough, and exertion-related shortness of breath
- Nocturnal or early-morning awakening cough and chest tightness
- Recurrent asthma attacks triggered by upper respiratory tract infections
- Variable airflow limitation on spirometry or a positive bronchodilator response
- Symptoms triggered by exercise, allergens, cold air, or tobacco smoke exposure
- Increased attack frequency or loss of control in a previously diagnosed child
Preparation
- Detailed history; symptom frequency, nocturnal awakening, attack triggers, and family history are reviewed
- Spirometry and bronchial provocation/reversibility testing are planned in selected children
- Co-existing allergic rhinitis, sinusitis, or reflux are screened
- An age- and adherence-appropriate spacer is selected, with a face mask for younger children
- Information is provided about indoor triggers such as tobacco smoke, animal dander, and mold
How it's performed
- Treatment follows a stepwise approach; low-dose inhaled corticosteroid (ICS) is preferred initially based on symptom frequency
- In adherent children over 5, the MART approach (single inhaler containing ICS + formoterol) may be used for both maintenance and reliever therapy
- At all ages, the metered-dose inhaler (MDI) is delivered with a spacer; a face mask is added in younger children
- A short-acting beta-2 agonist reliever (e.g., salbutamol) is used only as needed for symptoms
- Correct inhaler technique is reviewed at every visit and a written asthma action plan is provided to the family
- Treatment of co-existing allergic rhinitis and atopic dermatitis supports asthma control
Post-procedure
- Treatment response is assessed within 4-6 weeks of initiation; doses are reduced when appropriate
- Control status is monitored regularly with childhood asthma control tests and attack frequency
- Growth and development are followed annually
- Families are informed that low-dose ICS does not have a meaningful permanent effect on growth; uncontrolled asthma and frequent attacks have a greater impact
- Treatment plans are reviewed in advance during seasonal exacerbation periods
Risks
- Oral candidiasis and mild voice changes from inhaled corticosteroids (reduced with spacer use and mouth rinsing)
- Tremor, palpitations, or restlessness from frequent short-acting bronchodilator use
- Small, transient slowing of growth velocity with high-dose, long-term use
- Uncontrolled asthma and frequent attacks due to non-adherence or incorrect inhaler technique
FAQ
Do inhaler medications cause dependence?
No. Asthma medications do not cause dependence; on the contrary, when not used regularly, airway inflammation cannot be controlled and symptoms recur.
Will my child outgrow this condition?
In some children, symptoms decrease or resolve during adolescence; in others, they may continue into adulthood. Regular treatment and trigger avoidance support long-term control.
Is using a spacer essential?
Yes. In children, an MDI alone cannot be used effectively. The spacer increases the amount of medication reaching the lungs and reduces the amount left in the mouth and side effects. A face mask is added for younger children.
Can my child play sports?
Yes. With well-controlled asthma, sports are encouraged. For exercise-triggered symptoms, the physician arranges a separate plan for medication to be used before training.
Related Information
Related Medical Services
Other services in the same specialty or with similar indications you may want to explore.
Pediatric allergy testing
Pediatrics
Pediatric allergy testing — allergen diagnosis with skin prick test and specific IgE.
Neonatal jaundice treatment
Pediatrics
Neonatal jaundice treatment — control of elevated bilirubin with phototherapy and exchange transfusion when needed.
Pediatric infection treatment
Pediatrics
Pediatric infection treatment — differential diagnosis, rational antibiotic use, and viral infection management.
Pediatric urinary tract infection treatment
Pediatrics
Pediatric urinary tract infection — culture-guided antibiotic therapy and kidney-protective follow-up.
Pediatric upper respiratory tract infection treatment
Pediatrics
Pediatric upper respiratory tract infection — viral/bacterial differentiation and a rational antibiotic approach.
Neonatal intensive care service
Pediatrics
Neonatal intensive care unit — advanced care for premature infants and newborns with RDS, jaundice, and critical conditions.
Newborn screening
Pediatrics
Newborn screening test (heel prick) — early diagnosis prevents permanent damage.
Growth and Development Monitoring
Pediatrics
Growth and development monitoring — tracking height, weight, head circumference, and developmental milestones.